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Papillary Thyroid Carcinoma of a Diffuse
Sclerosing Variant: Ultrasonographic
Monitoring from a Normal Thyroid Gland
to Mass Formation
A diffuse sclerosing variant of papillary thyroid carcinoma is uncommon and
has a tendency for rapid growth and a higher incidence of cervical lymph node
metastases. We experienced a case of a diffuse sclerosing variant of papillary
thyroid carcinoma in a 48-year-old man. This case showed benign features on ini-
tial ultrasonography and positron emission tomography (PET) scan. A new nod-
ule was detected on follow-up ultrasonography that showed rapid enlargement.
This case was confirmed by surgical excision. We herein describe the initial and
follow-up ultrasonographic findings of a diffuse sclerosing variant of papillary thy-
roid carcinoma.
ost papillary thyroid carcinomas (PTC) are known as slow growing
tumors with a favorable prognosis. A diffuse sclerosing variant of
papillary thyroid carcinoma (DSVPTC) is uncommon and has a higher
incidence of cervical lymph node metastases, compared with classic PTC (1, 2).
Several articles recently reported the imaging findings and pathologic features of
DSVPTC. Here, we describe a recently developed case of DSVPTC, which manifested
as thyroiditis with a rapidly enlarging suspicious mass from a normal thyroid gland.
The finding was noted at the time of two year follow-up ultrasonographic examina-
tion.
CASE REPORT
A 48-year-old man visited our hospital to be screened for cancer. His history and
physical examination were unremarkable. His initial thyroid ultrasonography (Logic
700, GE Healthcare, Milwaukee, WI) and positron emission tomography (Advance,
GE Healthcare, Milwaukee, WI) with F-18-deoxyglucose positron emission tomogra-
phy (FDG-PET) were normal (Fig. 1A, B).
The man returned for a second-round cancer screening two years later. His physical
examination and laboratory findings were also unremarkable; serum triiodothyronine
(T3) 105 ng/dl (76-190), free T4 1.34 ng/dl (0.79-1.86), thyroid-stimulating hormone
(TSH) 7.00 uIU/ml (0.3-6.00), total iron binding capacity (TIBC) 350 μ g/dl (250-425).
A second-round screening ultrasonography (iU 22 unit, Philips Healthcare, Bothell,
WA) showed a mild heterogeneous parenchymal change with a suspicious mass
located on an enlarged left lobe of the thyroid gland. The mass was regarded as likely
being benign (Fig. 1C, D), therefore a follow-up ultrasonography was recommended.
FDG-PET scan (Discovery STE16, GE Healthcare, Milwaukee, WI) showed diffusely
increased FDG uptake in the left thyroid gland, which was also interpreted as benign
thyroid disease.




Jung Hee Shin, MD
2
Eun Young Ko, MD
2
Chang Ohk Sung, MD
3
Young Lyun Oh, MD
3







Korean J Radiol 2010;11:579-582
Received December 21, 2009; accepted 
after revision April 12, 2010.
1Center for Health Promotion;
2Department of Radiology and Center for
Imaging Science; 
3Department of
Pathology, Samsung Medical Center,
Sungkyunkwan University School of
Medicine, Seoul 135-710, Korea
Corresponding author:
Boo-Kyung Han, MD, Department of
Radiology, Samsung Medical Center,
Sungkyunkwan University School of





MA follow-up ultrasonography performed six months after
the second-round screening ultrasonography demonstrated
a partially ill-defined hypoechoic mass with multiple
microcalcifications and cystic portions in the mid-region of
left thyroid gland (Fig. 1E). His physical examination
remained unremarkable. The size of this ultrasonographic
mass was about 1.6 cm, and the left thyroid gland was
diffusely enlarged with a snow-storm appearance, suggest-
ing multiple scattered microcalcifications in the surround-
ing parenchyma (Fig. 1F). Vascularity of the left thyroid
gland was generally increased on a color Doppler image.
Multiple lymph nodes were found along left internal
jugular chains (Fig. 1G). Some nodes showed multiple
microcalcifications in the cortices, while the others showed
loss of a hilum. Another 3-mm hypoechoic nodule with an
ill-defined margin was newly noted in the mid-deep region
of the right thyroid gland.
Fine-needle aspiration biopsies (FNAB) of the left
thyroid mass and a lymph node were performed. The
results of the FNAB indicated papillary thyroid carcinoma
and lymph node metastasis. The laboratory findings,
including an anti-microsomal antibody (AMA), anti-TSH-
receptor antibody (TRAb) and, anti-thyroglobulin antibody
(ATA) activity were checked at the same time. AMA was
positive, whereas all other findings were negative; AMA
203 U/ml (0-100), TRAb -0.5% (-15-15), ATA 12 U/ml
(0-100). A total thyroidectomy with modified radical neck
dissection was performed. The specimen size of each
thyroid gland lobe was 4.5 × 2.5 × 2.0 cm on the right
side and 5.0 × 4.0 × 2.0 cm on the left side. Each lobe
weighed 12 grams on the right side and 18 grams on the
left side. The left thyroid gland was replaced by multiple
masses with capsular invasion. The pathologic diagnosis
was a DSVPTC in both lobes, with multiple lymph node
metastases in the left lateral neck (Fig. 1H). The patient
was treated with I-131 (150 mCi).
DISCUSSION
Diffuse sclerosing variant of PTC is an uncommon
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Fig. 1. Diffuse sclerosing variant of papillary thyroid carcinoma in 48-year-old man.
A, B. Initial thyroid ultrasonography (A) and PET scan (B) have normal appearance. 
C, D. Second-round screening examination was performed two years later. Ultrasonography (C) shows diffuse enlargement of left thyroid
gland with heterogeneous echogenicity and formation of suspicious mass. It is regarded as pseudo-mass by heterogeneous parenchyma
of left thyroid. PET scan (D) shows increased FDG uptake in both thyroid glands, especially in left lobe. These findings are regarded as
benign thyroid disease and call for recommended follow-up examination.
Cvariant of papillary thyroid carcinoma and is considered to
have an unfavorable prognosis. It occurs in young individ-
uals, ranging from 19.5 to 34.7 years and has a higher
incidence of cervical lymph node metastases, compared
with classic PTC (1, 2). According to several reports (3, 4),
the prevalence of DSVPTC of all papillary carcinomas has
been reported to be 0.3% to 5.3%. DSVPTC is histologi-
cally characterized by diffuse involvement of one or both
thyroid lobes with dense fibrosis, extensive squamous
metaplasia, patchy lymphoid infiltration with germinal
centers, psammoma bodies, and areas of conventional
papillary carcinoma (1, 5). The usual ultrasonographic
findings of DSVPTC are a round, solid, hypoechoic mass
with internal vascularity and microcalcifications, or a
diffusely enlarged thyroid gland with hypoechoic and
heterogeneous internal echoes containing fine and multiple
fine high-echo spots (6-8). The diffuse involvement of the
thyroid in DSVPTC and the presence of anti-thyroglobulin
antibodies usually mimic Hashimoto’s thyroiditis (9).
Underlying diffusely scattered microcalcifications are
manifested to the prominent snow-storm appearance on
ultrasonography.
This issue involving this variant is often delayed diagno-
sis due to the imaging features mimicking benign thyroid
disease such as chronic thyroiditis (8). In our case, the
diagnosis was also delayed for the same reason. Initial
ultrasonography and PET scan was found to be normal.
For the second-round screening examination, ultrasonogra-
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Fig. 1. Diffuse sclerosing variant of papillary thyroid carcinoma in 48-year-old man.
E, F. Follow-up examination was performed six months later. Ultrasonography shows well defined cystic and solid mass (arrows)
measuring 16 mm at left thyroid gland (E, F). It also shows multiple internal microcalcifications within this mass and multiple high echoic
dots suggesting microcalcifications (arrowheads in F). 
G. Lymph node of left level III shows nodular cortical thickening and microcalcifications. Metastasis was confirmed by surgery. 
H. Photomicrograph shows mass (arrows) with multiple internal psammoma bodies (arrowheads) (Hematoxylin and Eosin staining, ×
20).
GHphy showed diffuse parenchymal enlargement, suspicious
mass formation, multiple microcalcifications and PET scan
also showed diffusely increased uptake on the left thyroid
gland, suggesting an abnormality. However, the physical
examination and laboratory findings were unremarkable.
The initial diagnosis was diffuse parenchymal change
rather than a mass lesion on the left thyroid gland. A
round, solid, and hypoechoic mass was finally detected on
a follow-up at six months after the second-round cancer
screening and two years and six months after the initial
examination. When confirming DSVPTC by FNAB, ATA
activity was also checked and was found to be negative.
The higher frequency of ATA positivity was consistent
shown in other reports (3, 10), accounting for 72-75% of
DSVPTC. However, this case showed that AMA was only
positive. A recent report (4) showed that only 25% (2 of 8)
of DSVPTC were positive to AMA and they were all in the
euthyroid state. As a result of this study, if we suspect this
disease due to any change on image or laboratory findings,
despite the initial normal finding, we found it to be
important to keep observing the follow-up ultrasonogra-
phy within the next six months. We also learned that a fine
needle aspiration biopsy may be necessary when the
ultrasonographic findings have changed.
Although DSVPTC is believed to be more aggressive
than classic papillary carcinoma (6), some recent studies
found that the prognosis of DSVPTC was similar to classic
papillary carcinoma owing to aggressive treatment and
close follow-up (2, 3).
In conclusion, we should be familiar with the findings of
the DSVPTC, such as diffuse enlargement of the thyroid
gland and multiple scattered microcalcifications with or
without mass formation. The final diagnosis should only be
given after a biopsy.
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